Shares of carbonate fuel cell technology developer FuelCell Energy (NASDAQ:FCEL)
jumped 6.8% in the afternoon session after it announced a strategic collaboration with Sustainable Development Capital (SDCL) to explore providing power for data centers. The partnership planned to deploy up to 450 megawatts of FuelCell's advanced power systems to support the growth of data centers and other critical power needs around the world. This move was driven by the rapid expansion of artificial intelligence, which has created a surging demand for electricity that is outpacing what the traditional power grid can supply. The collaboration aimed to address this challenge by offering a direct power source that bypasses grid limitations, providing the steady, high-density power that modern data centers require.
Shares of computer processor maker Intel (NASDAQ:INTC)
jumped 2.6% in the afternoon session after Wall Street signaled belief in the turnaround narrative, as the company received a dual vote of confidence from major analyst firms just days before its fourth-quarter earnings report.
Shares of fertility benefits company Progyny (NASDAQ:PGNY)
jumped 3.3% in the afternoon session after Citizens upgraded the fertility benefits company's stock from Market Perform to Market Outperform, setting a price target of $30.00.
Shares of behavioral health company Acadia Healthcare (NASDAQ:ACHC)
jumped 24% in the afternoon session after the company announced the departure of Christopher H. Hunter and immediately reappointed former CEO Debra K. Osteen to lead.
Shares of electrical energy control systems manufacturer Powell (NYSE:POWL) jumped 3% in the afternoon session after Roth Capital raised its price target on the company's shares to $450 from $350, while maintaining a 'Buy' rating.
Shares of pharmaceutical company Organon (NYSE:OGN)
jumped 8.9% in the afternoon session after reports surfaced that Sun Pharmaceutical Industries submitted a non-binding proposal to acquire the company.
Shares of nutrition products company Bellring Brands (NYSE:BRBR)
jumped 9.5% in the afternoon session after a major industry peer validated the company's core growth thesis.
Shares of health insurance company Clover Health (NASDAQ:CLOV) jumped 2.5% in the afternoon session after Canaccord Genuity maintained its 'Buy' rating and $3.70 price target on the company.
